Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats

Translational Research

Volumn 163, Issue 3, 2014, Pages 221-231

  Shivaswamy, Vijay ^a,b   Bennett, Robert G ^a,b   Clure, Cara C ^b   Ottemann, Brendan ^b   Davis, John S ^a,b   Larsen, Jennifer L ^a,b   Hamel, Frederick G ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PIG INSULIN; PROTEIN KINASE B; RAPAMYCIN; TACROLIMUS;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EXOCRINE CELL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; MUSCLE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; WEIGHT GAIN; WESTERN BLOTTING;

ADIPOSE TISSUE; ANIMALS; FEMALE; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SIGNAL TRANSDUCTION; SIROLIMUS; TACROLIMUS; TRANSPLANTS;

EID: 84895893008     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.12.002     Document Type: Article

References (36)

1. F. Batista, I. Auyanet, J.V. Torregrosa, and F. Oppenheimer Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation Transplant Proc 44 2012 2582 2584
2. L. Ye, B. Varamini, D.W. Lamming, D.M. Sabatini, and J.A. Baur Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 Front Genet 3 2012 177
3. E. Porrini, J.M. Moreno, and A. Osuna et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study Transplantation 85 2008 1133 1138
4. M. Roland, P. Gatault, and C. Doute et al. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation Transplant Int 21 2008 523 530
5. E. Gyurus, Z. Kaposztas, and B.D. Kahan Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens Transplant Proc 43 2011 1583 1592
6. V. Shivaswamy, R.G. Bennett, C.C. Clure, J.L. Larsen, and F.G. Hamel Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats Transplantation 95 2012 280 284
7. B.P. Boerner, V. Shivaswamy, C.V. Desouza, and J.L. Larsen Diabetes and cardiovascular disease following kidney transplantation Curr Diabetes Rev 7 2011 221 234
8. M. Honda, K. Asonuma, and S. Hayashida et al. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients Clin Transplant 27 2013 426 635
9. M.L. Griffith, M. Jagasia, and S.M. Jagasia Diabetes mellitus after hematopoietic stem cell transplantation Endocr Pract 16 2010 699 706
10. H. Bedanova, J. Ondrasek, and J. Cerny et al. Impact of diabetes mellitus on survival rates after heart transplantation Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153 2009 283 287
11. V. Bonato, D. Cataldo, F. Dotta, and M. Carmellini Diagnosis and approach to posttransplant diabetes Curr Diabet Rep 9 2009 317 323
12. E. Sulanc, J.T. Lane, S.E. Puumala, G.C. Groggel, L.E. Wrenshall, and R.B. Stevens New-onset diabetes after kidney transplantation: an application of 2003 international guidelines Transplantation 80 2005 945 952
13. M. Silverborn, A. Jeppsson, G. Martensson, and F. Nilsson New-onset cardiovascular risk factors in lung transplant recipients J Heart Lung Transplant 24 2005 1536 1543
14. B.L. Kasiske, J.J. Snyder, D. Gilbertson, and A.J. Matas Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178 185
15. M. Hecking, J. Werzowa, and M. Haidinger et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment Nephrol Dial Transplant 28 2013 550 566
16. C. Krautz, S. Wolk, and A. Steffen et al. Effects of immunosuppression on alpha and beta cell renewal in transplanted mouse islets Diabetologia 56 2013 1596 1604
17. S.A. Soleimanpour, M.F. Crutchlow, and A.M. Ferrari et al. Calcineurin signaling regulates human islet {beta}-cell survival J Biol Chem 285 2010 40050 40059
18. F. Li, and Q. Li Effects of different dose of FK506 on endocrine function of pancreatic islets and damage of beta cells of pancreatic islets in a Wistar rat model Immunopharmacol Immunotoxicol 32 2010 333 338
19. J.L. Larsen, R.G. Bennett, and T. Burkman et al. Tacrolimus and sirolimus cause insulin resistance in normal Sprague Dawley rats Transplantation 82 2006 466 470
20. M.J. Pereira, J. Palming, and M. Rizell et al. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue Mol Cell Endocrinol 365 2012 260 269
21. L.A. Ozbay, N. Moller, and C. Juhl et al. The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients Diabetes Med 29 2012 e440 e444
22. M. Bulanowski, J. Chudek, and A. Wiecek Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation Ann Transplant 17 2012 61 68
23. T. Havrdova, T. Jedinakova, K. Lipar, J. Skibova, and F. Saudek Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period Transplant Proc 43 2011 3270 3272
24. L.A. Ozbay, N. Moller, and C. Juhl et al. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers Br J Clin Pharmacol 73 2011 536 545
25. I. Perez-Flores, A. Sanchez-Fructuoso, N. Calvo, E.F. Valga, and A. Barrientos Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus Transplant Proc 42 2010 2902 2904
26. S.M. Blattler, J.T. Cunningham, and F. Verdeguer et al. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling Cell Metab 15 2012 505 517
27. N. Deblon, L. Bourgoin, and C. Veyrat-Durebex et al. Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats Br J Pharmacol 165 2011 2325 2340
28. A.D. Barlow, J. Xie, and C.E. Moore et al. Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2) Diabetologia 55 2012 1355 1365
29. C. Kilkenny, W.J. Browne, I.C. Cuthill, M. Emerson, and D.G. Altman Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol 8 2010 e1000412
30. A. Volosov, K.L. Napoli, and S.J. Soldin Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass spectrometry Clin Biochem 34 2001 285 290
31. M.D. Abramoff, P.J. Magalhaes, and S.J. Ram Image processing with Image J Biophot Int 11 2004 36 42
32. C. Guerra, P. Navarro, and A.M. Valverde et al. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance J Clin Invest 108 2001 1205 1213
33. G.Y. Yang, J.S. Yao, M. Huey, T. Hashimoto, and W.L. Young Participation of PI3K and ERK1/2 pathways are required for human brain vascular smooth muscle cell migration Neurochem Int 44 2004 441 446
34. K.L. Roehrig, and J.B. Allred Direct enzymatic procedure for the determination of liver glycogen Anal Biochem 58 1974 414 421
35. G.J. McKenna, J.F. Trotter, and E. Klintmalm et al. Sirolimus and cardiovascular disease risk in liver transplantation Transplantation 95 2012 215 221
36. S. Celik, A. Doesch, and C. Erbel et al. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients Transplantation 86 2008 245 250